AU1809499A - Self-emulsifying fenofibrate formulations - Google Patents
Self-emulsifying fenofibrate formulationsInfo
- Publication number
- AU1809499A AU1809499A AU18094/99A AU1809499A AU1809499A AU 1809499 A AU1809499 A AU 1809499A AU 18094/99 A AU18094/99 A AU 18094/99A AU 1809499 A AU1809499 A AU 1809499A AU 1809499 A AU1809499 A AU 1809499A
- Authority
- AU
- Australia
- Prior art keywords
- self
- fenofibrate formulations
- emulsifying
- emulsifying fenofibrate
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98827097A | 1997-12-10 | 1997-12-10 | |
US08988270 | 1997-12-10 | ||
US4994298A | 1998-03-30 | 1998-03-30 | |
US09049942 | 1998-03-30 | ||
PCT/US1998/026075 WO1999029300A1 (en) | 1997-12-10 | 1998-12-10 | Self-emulsifying fenofibrate formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1809499A true AU1809499A (en) | 1999-06-28 |
Family
ID=26727723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18094/99A Abandoned AU1809499A (en) | 1997-12-10 | 1998-12-10 | Self-emulsifying fenofibrate formulations |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1809499A (en) |
WO (1) | WO1999029300A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL138765A0 (en) * | 1998-03-30 | 2001-10-31 | Rtp Pharma Inc | Compositions containing microparticles of water-insoluble substances and method for their preparation |
US6337092B1 (en) | 1998-03-30 | 2002-01-08 | Rtp Pharma Inc. | Composition and method of preparing microparticles of water-insoluble substances |
JP2002513750A (en) * | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | Solvent / co-solvent free microemulsion and emulsion pre-concentrate drug delivery system |
EP1165141A2 (en) * | 1999-03-31 | 2002-01-02 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
EP1162954A1 (en) * | 1999-03-31 | 2001-12-19 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
US6372251B2 (en) | 1999-06-11 | 2002-04-16 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6982281B1 (en) | 2000-11-17 | 2006-01-03 | Lipocine Inc | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
AU2006201100B2 (en) * | 1999-09-21 | 2009-09-24 | Jagotec Ag | Surface modified particulate compositions of biologically active substances |
DE60020382T2 (en) * | 1999-09-21 | 2006-01-26 | Skyepharma Canada Inc., Verdun | SURFACE-MODIFIED PARTICULATE COMPOSITIONS OF BIOLOGICALLY ACTIVE SUBSTANCES |
WO2001028519A1 (en) | 1999-10-20 | 2001-04-26 | Vesifact Ag | Microemulsion preconcentrates and microemulsions |
FR2803203B1 (en) * | 1999-12-31 | 2002-05-10 | Fournier Ind & Sante | NEW GALENIC FORMULATIONS OF FENOFIBRATE |
EP1118333A1 (en) * | 2000-01-18 | 2001-07-25 | Eurand International S.P.A. | Compositions with enhanced oral bioavailability |
US7276249B2 (en) * | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
US20030224058A1 (en) * | 2002-05-24 | 2003-12-04 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
GB0119480D0 (en) * | 2001-08-09 | 2001-10-03 | Jagotec Ag | Novel compositions |
EP1539117A4 (en) * | 2002-06-28 | 2005-12-14 | Shire Lab Inc | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
US20040005339A1 (en) * | 2002-06-28 | 2004-01-08 | Shojaei Amir H. | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
EP1569623B1 (en) | 2002-12-13 | 2008-10-15 | Jagotec Ag | A topical nanoparticulate spironolactone formulation |
US20050074469A1 (en) * | 2003-10-03 | 2005-04-07 | Charles Signorino | Stable lipophilic emulsions for acrylic coating and method of making |
WO2005037250A1 (en) * | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self emulsifying drug delivery systems for hydrophobic therapeutic compounds |
WO2005037251A1 (en) * | 2003-10-17 | 2005-04-28 | Amylin Pharmaceuticals, Inc. | Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds |
JP4994039B2 (en) * | 2003-11-26 | 2012-08-08 | スパーナス ファーマシューティカルズ インコーポレイテッド | Micellar system useful for delivery of lipophilic or hydrophobic compounds |
US7790190B2 (en) * | 2004-03-20 | 2010-09-07 | Yasoo Health, Inc. | Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid |
NZ552390A (en) * | 2004-08-06 | 2010-01-29 | Transform Pharmaceuticals Inc | Novel fenofibrate formulations and related methods of treatment |
US8026281B2 (en) | 2004-10-14 | 2011-09-27 | Lupin Atlantis Holdings, S.A. | Treating metabolic syndrome with fenofibrate |
KR20080033410A (en) * | 2005-08-04 | 2008-04-16 | 트렌스폼 파마수티컬스 인코퍼레이티드 | Novel formulations comprising fenofibrate and a statin, and related methods of treatment |
WO2008144355A2 (en) * | 2007-05-17 | 2008-11-27 | Morton Grove Pharmaceuticals, Inc. | Stable, self-microemulsifying fenofibrate compositions |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
EP2405903B1 (en) | 2009-03-09 | 2024-04-10 | Basf As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
CN102802624A (en) * | 2009-06-19 | 2012-11-28 | 太阳医药高级研发有限公司 | Nanodispersion Of A Drug And Process For Its Preparation |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
EP2878311A1 (en) * | 2013-11-27 | 2015-06-03 | Freund Pharmatec Ltd. | Solubility Enhancement for Hydrophobic Drugs |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
CN108014170A (en) * | 2016-11-04 | 2018-05-11 | 珠海天凯生物科技有限公司 | Wild marjoram oil emu and preparation method thereof |
WO2018098501A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
CN109431999B (en) * | 2018-12-18 | 2021-02-19 | 华南农业大学 | Nano self-microemulsion, veterinary drug nano self-microemulsion and preparation method and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (en) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE |
FR2617047B1 (en) * | 1987-06-23 | 1991-05-10 | Sanofi Sa | TANNING RESISTANT GELATIN COMPOSITION, CAPSULES BASED ON THIS COMPOSITION AND THEIR PHARMACEUTICAL APPLICATION, IN PARTICULAR TO FENOFIBRATE |
FR2627696B1 (en) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | NEW GALENIC FORM OF FENOFIBRATE |
CA2091152C (en) * | 1993-03-05 | 2005-05-03 | Kirsten Westesen | Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |
US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
FR2730231B1 (en) * | 1995-02-02 | 1997-04-04 | Fournier Sca Lab | COMBINATION OF FENOFIBRATE AND VITAMIN E, USE IN THERAPEUTICS |
FR2737121B1 (en) * | 1995-07-27 | 1997-10-03 | Cl Pharma | NEW GALENIC FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS |
-
1998
- 1998-12-10 WO PCT/US1998/026075 patent/WO1999029300A1/en active Application Filing
- 1998-12-10 AU AU18094/99A patent/AU1809499A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999029300A1 (en) | 1999-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1809499A (en) | Self-emulsifying fenofibrate formulations | |
AU1617399A (en) | Glp-1 formulations | |
AU7389098A (en) | Local anesthetic formulations | |
AU6244098A (en) | Distributed game | |
AU6562298A (en) | Peptide-enhanced transfections | |
AU7582298A (en) | Tissue specific prodrug | |
AU3345195A (en) | Surface-active formulations | |
AU3345295A (en) | Surface-active formulations | |
AU5875098A (en) | Processor | |
AU6042298A (en) | Tissue factor pathway inhibitor-3 | |
AUPO714197A0 (en) | Multi-strategy array processor | |
AU7265596A (en) | Probiotically acting formulations | |
AUPO907397A0 (en) | Game | |
AU3902895A (en) | Solid glyphosate formulations | |
AU3261297A (en) | New insecticide formulations | |
AU3129097A (en) | Explosive formulations | |
AU7604096A (en) | Gameboard | |
AU8233098A (en) | Game | |
AUPM926794A0 (en) | Herbicidal formulations | |
AU8155898A (en) | Human preprotachykinin b | |
AU1645599A (en) | Human matrilin-3 | |
AU3069697A (en) | Explosive formulations | |
AU9338498A (en) | Chair | |
AU3129197A (en) | Explosive formulations | |
AU8012898A (en) | Formulations containing surfactants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |